On July 28, 2023, Paul Jones, Chief People Officer of Usana Health Sciences Inc (USNA, Financial), sold 3,682 shares of the company. This move is part of a trend observed over the past year, where Jones has sold a total of 3,682 shares and purchased none.
Paul Jones is a key figure in Usana Health Sciences Inc, a company that develops and manufactures high-quality nutritional and personal care products. The company's mission is to develop and provide the highest quality, science-based health products, distributed internationally through network marketing, creating a rewarding financial opportunity for our Independent Associates, shareholders, and employees.
The insider transaction history for Usana Health Sciences Inc shows a trend towards selling rather than buying. Over the past year, there have been 22 insider sells and no insider buys. This trend is visualized in the following image:
On the day of Jones's recent sell, shares of Usana Health Sciences Inc were trading for $65 apiece, giving the stock a market cap of $1.252 billion. The price-earnings ratio is 19.79, which is slightly higher than the industry median of 19.78 and higher than the company’s historical median price-earnings ratio.
Despite the insider selling trend, the stock appears to be modestly undervalued based on its GuruFocus Value. With a price of $65 and a GuruFocus Value of $76.76, Usana Health Sciences Inc has a price-to-GF-Value ratio of 0.85. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples, a GuruFocus adjustment factor, and future estimates of business performance from Morningstar analysts. The GF Value is visualized in the following image:
In conclusion, while the insider selling trend, particularly from Chief People Officer Paul Jones, may raise some eyebrows, the stock's current valuation suggests that it may still be a good buy for investors. However, as always, investors should conduct their own due diligence before making any investment decisions.
